Figure 4.
Healthcare use among 6442 adult patients with AML who received cytarabine-anthracycline-based IC by age.

Healthcare use among 6442 adult patients with AML who received cytarabine-anthracycline-based IC by age.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal